p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors
- PMID: 3915536
- PMCID: PMC367026
- DOI: 10.1128/mcb.5.10.2851-2855.1985
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors
Abstract
The relative levels of mRNA specific for the mouse p53 cellular tumor antigen were determined in various normal adult tissues, embryos, and tumors. All tumors studied contained concentrations of p53 mRNA well above those present in most normal tissues. Normal spleen, however, had p53 mRNA levels comparable to those found in some tumors, despite the fact that they contained barely detectable p53 protein. This apparent discrepancy was found to be due to the extremely rapid turnover rate of p53 in the spleen (half-life, approximately equal to 6 min). In developing fetuses, a marked reduction of p53 mRNA levels was manifest from day 11 onwards, whereas the levels during organogenesis (days 9 to 11) were comparable to those found in undifferentiated embryonic stem cells and in some tumors.
Similar articles
-
The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates.Biochim Biophys Acta. 1988 Sep 7;950(3):395-402. doi: 10.1016/0167-4781(88)90136-4. Biochim Biophys Acta. 1988. PMID: 3048409
-
Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen.J Virol. 1989 Feb;63(2):790-7. doi: 10.1128/JVI.63.2.790-797.1989. J Virol. 1989. PMID: 2642978 Free PMC article.
-
Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.Mol Cell Biol. 1983 Dec;3(12):2143-50. doi: 10.1128/mcb.3.12.2143-2150.1983. Mol Cell Biol. 1983. PMID: 6318085 Free PMC article.
-
The p53 cellular tumor antigen: gene structure, expression and protein properties.Biochim Biophys Acta. 1985 Nov 12;823(1):67-78. doi: 10.1016/0304-419x(85)90015-0. Biochim Biophys Acta. 1985. PMID: 3902087 Review. No abstract available.
-
p53: a potential target antigen for immunotherapy of cancer.Ann N Y Acad Sci. 2000 Jun;910:223-33; discussion 233-6. doi: 10.1111/j.1749-6632.2000.tb06711.x. Ann N Y Acad Sci. 2000. PMID: 10911916 Review.
Cited by
-
Driving apoptosis-relevant proteins toward neural differentiation.Mol Neurobiol. 2012 Oct;46(2):316-31. doi: 10.1007/s12035-012-8289-2. Epub 2012 Jul 1. Mol Neurobiol. 2012. PMID: 22752662 Review.
-
Regulation of Adult Neurogenesis in Mammalian Brain.Int J Mol Sci. 2020 Jul 9;21(14):4869. doi: 10.3390/ijms21144869. Int J Mol Sci. 2020. PMID: 32660154 Free PMC article. Review.
-
Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity.Genes Cancer. 2012 Mar;3(3-4):240-8. doi: 10.1177/1947601912455199. Genes Cancer. 2012. PMID: 23150757 Free PMC article.
-
Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53.J Virol. 1989 Apr;63(4):1792-9. doi: 10.1128/JVI.63.4.1792-1799.1989. J Virol. 1989. PMID: 2522559 Free PMC article.
-
Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up.Virchows Arch A Pathol Anat Histopathol. 1992;421(4):291-5. doi: 10.1007/BF01660975. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1413493
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous